Table 1 C-reactive protein is associated with the prevalence of bone marrow lesions (BMLs)
Predictor (continuous) | No BML (n = 287) Mean (SD) (Reference) | Prevalent BML (n = 56) Mean (SD) | Prevalent BML Crude OR (95% CI), p-value (per unit of biomarker concentration) | Prevalent BML Adjusted OR (95% CI), p-value (per unit of biomarker concentration) |
|---|---|---|---|---|
C-reactive Protein (mg/L) | 3.24 (1.22) | 3.67 (1.12) | 1.36 (1.05, 1.75), 0.02 | 1.43 (1.09, 1.87), 0.01 |
Glycated serum protein (log) | 5.50 (0.70) | 5.43 (0.82) | 0.87 (0.58, 1.32), 0.52 | 0.97 (0.65, 1.46), 0.90 |
Glucose (mg/dL) per 10Â mg/dL | 109.3 (27.2) | 114.6 (22.2) | 1.08 (0.97, 1.20), 0.18 | 1.07 (0.95, 1.19), 0.28 |